Review: Risk stratification in the hormonal treatment of patients with prostate cancer
Prostate cancer (PCa) is the most common type of cancer found in American men, other than skin cancer. The American Cancer Society estimates that there will be 186,320 new cases of prostate cancer in the United States in 2008. About 28,660 men will die of this disease this year and PCa remains the s...
Main Authors: | Matthew A. Uhlman, Judd W. Moul, Ping Tang, Danielle A. Stackhouse, Leon Sun |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2009-09-01
|
Series: | Therapeutic Advances in Medical Oncology |
Online Access: | https://doi.org/10.1177/1758834009340164 |
Similar Items
-
Hormone naïve prostate cancer: predicting and maximizing response intervals
by: Judd W Moul
Published: (2015-01-01) -
African American Men With Low-Risk Prostate Cancer Candidates for Active Surveillance: The Will-Rogers Effect?
by: Robert Qi, et al.
Published: (2017-11-01) -
On Risk Estimation versus Risk Stratification in Early Prostate Cancer.
by: Sigrid V Carlsson, et al.
Published: (2016-08-01) -
Clinical implications of genomic evaluations for prostate cancer risk stratification, screening, and treatment: a narrative review
by: Jae-Seung Chung, et al.
Published: (2020-09-01) -
Change in the risk stratification of prostate cancer after Slide Review by a uropathologist: the experience of a reference center for the treatment of prostate cancer
by: George Camara-Lopes, et al.
Published: (2014-08-01)